• FirefoxUpgrade to the new Firefox »
  •  Dow Up1.41% Nasdaq Up1.56%

    Keryx Biopharmaceuticals Inc. (KERX)

    -NasdaqCM
    14.59 Up 0.50(3.55%) 10:25AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
    Total Revenue 256   -   10,000   -  
    Cost of Revenue154   -   -   -  
    Gross Profit 102   -   10,000   -  
    Operating Expenses
    Research Development19,053  11,079  15,555  8,110  
    Selling General and Administrative16,447  11,464  8,096  9,629  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (35,398) (22,543) (13,651) (17,739)
    Income from Continuing Operations
    Total Other Income/Expenses Net109  129  121  71  
    Earnings Before Interest And Taxes(35,289)(22,414)(13,530)(17,668)
    Interest Expense -   -   -   -  
    Income Before Tax(35,289)(22,414)(13,530)(17,668)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(35,289)(22,414)(13,530)(17,668)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (35,289) (22,414) (13,530) (17,668)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (35,289) (22,414) (13,530) (17,668)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.